SENSEI BIOTHERAPEUTICS INC's ticker is SNSE and the CUSIP is 81728A108. A total of 24 filers reported holding SENSEI BIOTHERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,350,180 | -35.2% | 1,800,000 | -1.5% | 0.33% | -32.3% |
| Q2 2023 | $2,083,054 | -9.9% | 1,827,240 | +18.6% | 0.49% | +8.4% |
| Q1 2023 | $2,311,380 | +34.2% | 1,540,920 | +33.3% | 0.45% | +27.9% |
| Q4 2022 | $1,721,786 | +167.8% | 1,155,561 | +178.4% | 0.36% | +151.8% |
| Q3 2022 | $643,000 | -31.7% | 415,000 | 0.0% | 0.14% | -20.8% |
| Q2 2022 | $942,000 | – | 415,000 | – | 0.18% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Duquesne Family Office | 100,000 | $231,000 | 0.01% |
| FNY Investment Advisers, LLC | 3,500 | $8,000 | 0.01% |
| LEO BROKERAGE, LLC | 14,845 | $34,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 37,900 | $88,000 | 0.00% |
| UBS Group AG | 13,618 | $31,000 | 0.00% |
| RHUMBLINE ADVISERS | 16,169 | $37,000 | 0.00% |
| Ellevest, Inc. | 19 | $0 | 0.00% |
| TWO SIGMA INVESTMENTS, LP | 62,184 | $144,000 | 0.00% |
| FMR LLC | 179 | $0 | 0.00% |
| AMERICAN INTERNATIONAL GROUP, INC. | 10,375 | $24,000 | 0.00% |